“Out of an abundance of caution,” Johnson & Johnson MedTech has temporarily paused the use of its Varipulse field ablation system in the United States, the company announced. The move comes after the ...

VARIPURE demonstrated strong safety outcomes with no incidence of stroke and 99.7% acute effectiveness of the VARIPULSE™ Platform in nearly 800 enrolled patientsi VARIPURE, a SECURE substudy, is a ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Johnson & Johnson has launched the Varipulse Pro in Europe following CE mark approval, further advancing its pulsed-field ablation (PFA) portfolio. This new pulse sequence marks the next evolution of ...

Feb 14 (Reuters) - Johnson & Johnson (JNJ.N), opens new tab said on Friday it resumed the limited market release of its Varipulse heart device in the United States after an investigation found the ...

Jan 8 (Reuters) - Johnson & Johnson (JNJ.N), opens new tab said on Wednesday it had temporarily paused the rollout of its Varipulse heart device in the United States, as the company investigates four ...

On Wednesday, Johnson & Johnson (NYSE:JNJ) said it has temporarily paused all U.S. cases using its Varipulse pulsed field ablation (PFA) system. Pulsed-field ablation (PFA) is a non-thermal procedure ...

IRVINE, Calif.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) today announced the launch of VARIPULSE Pro in Europe following CE Mark approval, further advancing its pulsed field ablation (PFA) ...

Investing.com -- Shares of Johnson & Johnson (NYSE:JNJ) fell 3% amid concerns regarding its cardiac ablation device, Varipulse. The movement comes after Wells Fargo (NYSE:WFC) released a research ...

Johnson & Johnson MedTech's Varipulse picked up a CE mark in Europe and an approval in Japan at the top of this year. (Johnson & Johnson) Johnson & Johnson MedTech will enter the U.S. pulsed field ...